Advertisement

Mucocutaneous Manifestations with Gastrointestinal Disease

Chapter

Abstract

The gastrointestinal (GI) system is influenced by many factors that can cause age-related and pathological changes in the skin and organ systems. Several GI disorders are associated with cutaneous manifestations. A thorough understanding of the cutaneous–gastrointestinal relationship can alert the astute clinician to presence of GI disease in the older adult. This overview provides insight into mucocutaneous manifestations in GI disorders including manifestation, diagnosis, treatment, and prognosis. At times the presence of skin manifestations alerts a provider to a specific GI illness.

Keywords

Lichen Planus Epidermolysis Bullosa Cutaneous Manifestation Acanthosis Nigricans Dermatitis Herpetiformis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Forciea MA, Lavizzo-Mourne R, Schwab EP. Geriatric secrets. 2nd ed. Philadelphia: Hanley and Belfus; 2000. p. 127.Google Scholar
  2. 2.
    Schwartz RA, Lambert WC, Van Voorhees AS, et al. Kaposi sarcoma. http://emedicine.medscape.com/article/1083998-overview. Accessed 14 Feb 2011.
  3. 3.
    Schwartz RA, Cohen PF. Kaposi’s sarcoma. In: Newcomer VD, Young Jr EM, editors. Geriatric dermatology: clinical diagnosis and practical therapy. New York: Igaku-Shoin; 1989. p. 645–52.Google Scholar
  4. 4.
    Allan AE, Shoji T, Li N, et al. Two cases of Kaposi’s sarcoma mimicking Stewart-Treves syndrome found to be human herpesvirus-8 positive. Am J Dermatopathol. 2001;23(5):431–6.PubMedCrossRefGoogle Scholar
  5. 5.
    Young Jr EM, Newcomer VD, Kligman AM. Kaposi’s sarcoma. In: Geriatric dermatology: color atlas and practitioner’s guide. Philadelphia: Lea and Febiger; 1993. p. 202–3.Google Scholar
  6. 6.
    Klein E, Schwartz RA, Laor Y, et al. Treatment of Kaposi’s sarcoma with vinblastine. Cancer. 1980;45:427–31.PubMedCrossRefGoogle Scholar
  7. 7.
    Young Jr EM, Newcomer VD, Kligman AM. Superficial fungal infections. In: Geriatric dermatology: color atlas and practitioner’s guide. Philadelphia: Lea and Febiger; 1993. p. 107–9.Google Scholar
  8. 8.
    Sheinfeld NS, Lambiase MC, Lehman DS, Allan JM. Candidiasis, cutaneous. http://emedicine.medscape.com/article/1090632-overview. Accessed 20 Feb 2011.
  9. 9.
    Sundaram SV, Srinivas CR, Thirumurthy M. Candidal intertrigo: treatment with filter paper soaked in Castellani’s paint. Indian J Dermatol Venereol Leprol. 2006;72(5):386–7.PubMedCrossRefGoogle Scholar
  10. 10.
    Atmatzidis K, Papaziogas B, Pavlidis T, et al. Plummer-Vinson syndrome. Dis Esophagus. 2003;16(2):154–7.PubMedCrossRefGoogle Scholar
  11. 11.
    Hoffman RM, Jaffe PE. Plummer-Vinson syndrome. A case report and literature review. Arch Intern Med. 1995;155(18):2008–11.PubMedCrossRefGoogle Scholar
  12. 12.
    Harper PS, Harper RMJ, Howell Evans AW. Carcinoma of the oesophagus with tylosis. Q J Med. 1970;39:317–33.PubMedGoogle Scholar
  13. 13.
    May A, Gossner L, Behrens A, et al. A prospective randomized trial of two different endoscopic resection techniques for early stage cancer of the esophagus. Gastrointest Endosc. 2003;58(2):167–75.PubMedCrossRefGoogle Scholar
  14. 14.
    Woodley DT, Chen M. Epidermolysis bullosa: then and now. J Am Acad Dermatol. 2004;51(1 Suppl):S55–7.PubMedCrossRefGoogle Scholar
  15. 15.
    Berger TG, Detlefs RL, Donatucci CF. Junctional epidermolysis bullosa, pyloric atresia, and genitourinary disease. Pediatr Dermatol. 1986;3(2):130–4.PubMedCrossRefGoogle Scholar
  16. 16.
    Steen VD, Medsger Jr TA. Severe organ involvement in systemic sclerosis with diffuse scleroderma. Arthritis Rheum. 2000;43(11):2437–44.PubMedCrossRefGoogle Scholar
  17. 17.
    Rose S, Young MA, Reynolds JC. Gastrointestinal manifestations of scleroderma. Gastroenterol Clin North Am. 1998;27(3):563–94.PubMedCrossRefGoogle Scholar
  18. 18.
    Ashida R, Ihn H, Mimura Y, et al. Clinical and laboratory features of Japanese patients with scleroderma and telangiectasia. Clin Exp Dermatol. 2009;34(7):761–3.CrossRefGoogle Scholar
  19. 19.
    Ruben EC, Manuel VR, Agustin OR, et al. Ciprofloxin utility as antifibrotic in the skin of patients with scleroderma. J Dermatol. 2010;37(4):323–9.PubMedCrossRefGoogle Scholar
  20. 20.
    Lyell A. Toxic epidermal necrolysis: an eruption resembling scalding of the skin. Br J Dermatol. 1956;68(11):355–61.PubMedCrossRefGoogle Scholar
  21. 21.
    Miller JH, Rapini RP. Acanthosis nigricans. http://emedicine.medscape.com/article/1102488-overview. Accessed 20 Feb 2011.
  22. 22.
    Verrando P, Ortonne JP. Insulin binding properties of normal and transformed human epidermal cultured keratinocytes. J Invest Dermatol. 1985;85:328–32.PubMedCrossRefGoogle Scholar
  23. 23.
    Longshore SJ, Taylor JS, Kennedy A, Nurko S. Malignant acanthosis nigricans and endometrioid adenocarcinoma of the parametrium: the search for malignancy. J Am Acad Dermatol. 2003;49(3):541–3.PubMedCrossRefGoogle Scholar
  24. 24.
    Sinha S, Schwartz RA. Juvenile acanthosis nigricans. J Am Acad Dermatol. 2007;57(3):502–8.PubMedCrossRefGoogle Scholar
  25. 25.
    Ozdemir M, Toy H, Mevlitoglu I, et al. Generalized idiopathic acanthosis nigricans treated with acitreitn. J Dermatolog Treat. 2006;17:54–6.PubMedCrossRefGoogle Scholar
  26. 26.
    Darmstadt GL, Yokel BK, Horn TD. Treatment of acanthosis nigricans with tretinoin. Arch Dermatol. 1991;127:1139–40.PubMedCrossRefGoogle Scholar
  27. 27.
    Chevrant-Breton J, Simon M, Bourel M, Ferrand B. Cutaneous manifestations of idiopathic hermochromatosis. Study of 100 cases. Arch Dermatol. 1977;113(2):161–5.PubMedCrossRefGoogle Scholar
  28. 28.
    Brandhagen DJ, Fairbanks VF, Baldus W. Recognition and management of hereditary hemochromatosis. Am Fam Physician. 2002;65:853–60.PubMedGoogle Scholar
  29. 29.
    Drobnik J, Schwartz RA. Hemochromatosis. http://emedicine.medscape.com/article/1104743-overview. Accessed 24 Feb 2011.
  30. 30.
    Hazin R, Abu-Rajab Tamimi TI, Abuzetun JY, et al. Recognizing and treating cutaneous signs of liver disease. Cleve Clin J Med. 2009;76(10):599–606.PubMedCrossRefGoogle Scholar
  31. 31.
    Asare GA, Bronz M, Naidoo V, Kew MC. Synergistic interaction between excess hepatic iron and alcohol ingestion in hepatic mutagenesis. Toxicology. 2008;254(1–2):11–8.PubMedCrossRefGoogle Scholar
  32. 32.
    Kappas A, Sassa S, Galbraith RA, et al. The porphyrias. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The metabolic basis of inherited disease. New York: McGraw-Hill; 1995. p. 2103–59.Google Scholar
  33. 33.
    Elder GH, Smith SG, Herrero C, et al. Hepatoerythropoietic porphyria: a new uroporphyrinogen decarboxylase defect or homozygous porphyria cutanea tarda? Lancet. 1981;1(8226):916–9.PubMedCrossRefGoogle Scholar
  34. 34.
    Moran-Jimenez MJ, Ged C, Romana M, et al. Uroporphyrinogen decarboxylase: complete human gene sequence and molecular study of three families with hepatoerythropoietic porphyria. Am J Hum Genet. 1996;58(4):712–21.PubMedGoogle Scholar
  35. 35.
    Rocchi E, Cassanelli M, Borghi A, et al. Liver iron overload and desferrioxamine treatment of porphyria cutanea tarda. Dermatologica. 1991;182(1):27–31.PubMedCrossRefGoogle Scholar
  36. 36.
    Bonkovsky HL, Lambrecht RW, Shan Y. Iron as a co-morbid ­factor in nonhemochromatotic liver disease. Alcohol. 2003;30(2):137–44.PubMedCrossRefGoogle Scholar
  37. 37.
    Bonkovsky HL, Poh-Fitzpatrick M, Pimstone N, et al. Porphyria cutanea tarda, hepatitis C, and HFE gene mutations in North America. Hepatology. 1998;27(6):1661–9.PubMedCrossRefGoogle Scholar
  38. 38.
    Lambiase P, Seery JP, Taylor-Robinson SD, et al. Resolution of panniculitis after placement of pancreatic duct stent in chronic pancreatitis. Am J Gastroenterol. 1996;91(9):1835–7.PubMedGoogle Scholar
  39. 39.
    Chuang T-Y, Stitle L. Lichen planus. http://emedicine.medscape.com/article/1123213-overview. Accessed 1 Mar 2011.
  40. 40.
    Shengyuan L, Songpo Y, Wen W, et al. Hepatitis C virus and lichen planus: a reciprocal association determined by a meta-analysis. Arch Dermatol. 2009;145(9):1040–7.PubMedCrossRefGoogle Scholar
  41. 41.
    Ingafou M, Leao JC, Porter SR, Scully C. Oral lichen planus: a retrospective study of 690 British patients. Oral Dis. 2006;12(5):463–8.PubMedCrossRefGoogle Scholar
  42. 42.
    Balasubramaniam P, Ogboli M, Moss C. Lichen planus in children: review of 26 cases. Clin Exp Dermatol. 2008;33(4):457–9.PubMedCrossRefGoogle Scholar
  43. 43.
    Cribier B, Frances C, Chosidow O. Treatment of lichen planus. An evidence-based medicine analysis of efficacy. Arch Dermatol. 1998;134(12):1521–30.PubMedCrossRefGoogle Scholar
  44. 44.
    Hemminki A, Markie D, Tomlinson I, et al. A serine/threonine kinase gene defective in Peutz-Jeghers syndrome. Nature. 1998;391(6663):184–7.PubMedCrossRefGoogle Scholar
  45. 45.
    Jenne DE, Reimann H, Nezu J, et al. Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase. Nat Genet. 1998;18(1):38–43.PubMedCrossRefGoogle Scholar
  46. 46.
    Brosens LA, van Hattem WA, Jansen M, et al. Gastrointestinal polyposis syndromes. Curr Mol Med. 2007;7(1):29–46.PubMedCrossRefGoogle Scholar
  47. 47.
    Boardman LA, Thibodeau SN, Schaid DJ, et al. Increased risk for cancer in patients with the Peutz-Jeghers syndrome. Ann Intern Med. 1998;128(11):896–9.PubMedGoogle Scholar
  48. 48.
    Oranje AP. Blue rubber bleb nevus syndrome. Pediatr Dermatol. 1986;3(4):304–10 [Medline].PubMedCrossRefGoogle Scholar
  49. 49.
    Oksüzoglu BC, Oksüzoglu G, Cakir U, et al. Blue rubber bleb nevus syndrome. Am J Gastroenterol. 1996;91(4):780–2.PubMedGoogle Scholar
  50. 50.
    Apak H, Celkan T, Ozkan A, et al. Blue rubber bleb nevus syndrome associated with consumption coagulopathy: treatment with interferon. Dermatology. 2004;208(4):345–8.PubMedCrossRefGoogle Scholar
  51. 51.
    Gu GL, Wang SL, Wei XM, Bai L. Diagnosis and treatment of Gardner syndrome with gastric polyposis: a case report and review of the literature. World J Gastroenterol. 2008;14(13):2121–3.PubMedCrossRefGoogle Scholar
  52. 52.
    Ascari-Raccagni A, Baldari U, Righini MG. Cutaneous symptoms of Gardner’s syndrome. J Eur Acad Dermatol Venereol. 1999;12(1):80–1.PubMedCrossRefGoogle Scholar
  53. 53.
    Elkharwily A, Gottlieb K. The pancreas in familial adenomatous polyposis. J Pancreas. 2008;9(1):9–18.Google Scholar
  54. 54.
    Barta Z, Zold E, Nagy A, Zeher M, Csipo I. Celiac disease and microscopic colitis: a report of 4 cases. World J Gastroenterol. 2011;17(16):2150–4.PubMedCrossRefGoogle Scholar
  55. 55.
    Smith JB, Taylor TB, Zone JJ. The site of blister formation in dermatitis herpetiformis is within the lamina lucida. J Am Acad Dermatol. 1992;27(2 Pt 1):209–13.PubMedCrossRefGoogle Scholar
  56. 56.
    Akbulut S, Ozaslan E, Topal F, et al. Ulcerative colitis presenting as leukocytoclastic vasculitis of skin. World J Gastroenterol. 2008;14(15):2448–50.PubMedCrossRefGoogle Scholar
  57. 57.
    Eames T, Landthaler M, Karrer S. Crohn’s disease: an important differential diagnosis of granulomatous skin diseases. Eur J Dermatol. 2009;19(4):360–4.PubMedGoogle Scholar
  58. 58.
    Honchel R, Halling KC, Schaid DJ, et al. Microsatellite instability in Muir-Torre syndrome. Cancer Res. 1994;54(5):1159–63.PubMedGoogle Scholar
  59. 59.
    Ponti G, Losi L, Pedroni M, et al. Value of MLH1 and MSH2 mutations in the appearance of Muir-Torre syndrome phenotype in HNPCC patients presenting sebaceous gland tumors or keratoacanthomas. J Invest Dermatol. 2006;126(10):2302–7.PubMedCrossRefGoogle Scholar
  60. 60.
    Burger B, Itin P. Muir-Torre syndrome. Dermatology. 2008;217(1):56–7.PubMedCrossRefGoogle Scholar
  61. 61.
    Adkisson K, Fiala KH. Cowden disease (multiple hamartoma syndrome). http://emedicine.medscape.com/article/1093383-overview. Accessed 15 Mar 2011.
  62. 62.
    Cnudde F, Boulard F, Muller P, et al. Cowden disease: treatment with acitretine. Ann Dermatol Venereol. 1996;123(11):739–41.PubMedGoogle Scholar
  63. 63.
    Gray M. Optimal management of incontinence-associated dermatitis in the elderly. Am J Clin Dermatol. 2010;11(3):201–10.PubMedCrossRefGoogle Scholar
  64. 64.
    Abenavoli L, Proietti I, Vonghia L, et al. Intestinal malabsorption and skin disorders. Dig Dis. 2008;26(2):167–74.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  1. 1.Department of DermatologyNova Southeastern College of MedicineTampaUSA
  2. 2.Dermatology Healthcare, LLCTampaUSA

Personalised recommendations